Schally, A V <br/><br/>
Combination of a long-acting delivery system for luteinizing hormone-releasing hormone agonist with Novantrone chemotherapy: increased efficacy in the rat prostate cancer model.  [electronic resource] 

 -  Proceedings of the National Academy of Sciences of the United States of America  Nov 1986 
 - 8764-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0027-8424 
<br/><br/><label>Standard No.: </label>10.1073/pnas.83.22.8764  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Capsules<br/>Delayed-Action Preparations<br/>Disease Models, Animal<br/>Gonadotropin-Releasing Hormone--administration & dosage<br/>Male<br/>Mitoxantrone--administration & dosage<br/>Prostatic Neoplasms--drug therapy<br/>Rats<br/>Rats, Inbred Strains<br/>Triptorelin Pamoate